Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating-free DNA: A promising tool for early detection of myocardial infarction

5 Aug 2025

Abstract excerpt

Myocardial infarction (MI) is a leading global cause of mortality, necessitating novel biomarkers for early diagnosis and prognosis. This review explores circulating cell-free DNA (cfDNA) as a minimally invasive tool for MI detection, focusing on its mechanistic role, diagnostic accuracy, and potential in personalized medicine. CfDNA levels rise rapidly post-ischemic event, correlating with myocardial damage and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Renal cell carcinoma treatment
Share to Single-cell and spatial transcriptomics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40822890
DOI: 10.1016/j.ijcrp.2025.200484

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating-free DNA: A promising tool for early detection of myocardial infarctionPMID 40822890Read ↗

Cardiovascular disease biomarkers derived from circulating cell-free DNA methylationSemantic proximity Read ↗

Molecular and cellular pathophysiology of circulating cardiomyocyte-specific cell free DNA (cfDNA): Biomarkers of heart failure and potential therapeutic targetsSemantic proximity Read ↗

Technical Advances in Circulating Cell-Free DNA Detection and Analysis for Personalized Medicine in Patients’ CareSemantic proximity Read ↗

Cell-Free Circulating DNA: A New Biomarker for the Acute Coronary SyndromeSemantic proximity Read ↗

The emerging role of cell-free DNA as a molecular marker for cancer managementSemantic proximity Read ↗

Advances in cfDNA research for pregnancy-related diseasesSemantic proximity Read ↗

Cardiovascular disease biomarkers derived from circulating cell-free DNA methylationSemantic proximity Read ↗

Mitochondrial DNA Together with miR-142-3p in Plasma Can Predict Unfavorable Outcomes in Patients after Acute Myocardial InfarctionSemantic proximity Read ↗

Direct Quantification of Cell-Free, Circulating DNA from Unpurified PlasmaSemantic proximity Read ↗

Epigenetic-sensitive liquid biomarkers and personalised therapy in advanced heart failure: a focus on cell-free DNA and microRNAsSemantic proximity Read ↗

A Whole Blood Molecular Signature for Acute Myocardial InfarctionSemantic proximity Read ↗

Circulating Cell-Free DNA in Metabolic DiseasesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.